Ekuberg Pharma

What Ekuberg Pharma does

Ekuberg Pharma S.r.l. is a privately held Italian pharmaceutical company, headquartered in Carpignano Salentino (Lecce) with a foreign office in Milan, founded around 1999–2000 on a family-owned concept and operating for more than 25 years. The company researches, develops, produces, and markets cosmetic products and medical devices spanning Class I, IIA, IIB, and III risk classifications across eight therapeutic areas: gynaecology, dermatology, otolaryngology, paediatrics, trichology, wound care, andrology, and proctology. Its portfolio is organised around ten sub-brands — Dermoxen (women's intimate health), DermoACM (dermatology and scleroderma care), BioAke and BioAke PLUS (CBD/hemp-based cosmeceuticals and supplements), Freenex (nasal care medical devices), Liceout (paediatric anti-lice), Medoto (ear canal spray), Lecoxen (wound care), Hemopran (proctology), and Semyn (andrology supplements).

The underlying technology base rests on plant-derived active ingredients, formulation R&D supported by laboratory and clinical research (including GLP-ECVAM safety testing), international patents, and collaborations with Italian and international universities such as Università del Salento. The company maintains a portfolio of more than 10 peer-reviewed clinical publications (2012–2025) and participates in the UNIHEMP European bioeconomy project focused on hemp cultivation waste valorisation. R&D output is reported at approximately 500 scientific research hours per year.

Ekuberg Pharma generates revenue through two principal streams: (1) branded product sales distributed internationally through a network of 70 partners across more than 30 countries in Africa, Europe, Asia, and the USA, complemented by direct enterprise sales via its Milan office; and (2) private label development services for international pharmaceutical companies and large pharmacy buying groups, covering needs analysis, formula development, regulatory affairs, clinical study management, communication strategy, and medical-representative training. Pricing is not publicly disclosed. The company employs 51–100 people and holds registered capital of €100,000, indicating a mid-sized, founder/family-controlled operator with a globally distributed yet capital-light footprint.

Name

Ekuberg Pharma

Legal name

Ekuberg Pharma S.u.r.l.

Website

https://ekubergpharma.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Ekuberg Pharma is a privately held Italian pharmaceutical company that develops, produces, and markets cosmetic products and medical devices (Class I–III) across eight therapeutic areas, serving international pharmaceutical distributors, pharmacy groups, and patients in over 30 countries.

Ownership category

akta.pro rank

Product category

Cosmetics and Medical Devices

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Cosmetic products manufacturing
• Medical device development
• Private label pharmaceuticals
• Dermatological skincare products
• Wound care solutions

Headquarters

HQ city

Carpignano Salentino

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Cosmetic Products and Medical Devices: Ekuberg Pharma generates revenue through the research, development, production, and marketing of cosmetic products and medical devices (Class I, IIA, IIB, III) across seven therapeutic areas: gynaecology, dermatology, otolaryngology, paediatrics, trichology, wound care, and andrology. Products are sold through private label agreements with pharmaceutical companies and pharmacy distribution groups, and through branded product lines distributed internationally.
2. Private Label Development Services: Ekuberg Pharma offers full-service private label project development for pharmaceutical companies and pharmacy buying groups, covering needs analysis, formula development with safety and efficacy testing (GLP-ECVAM standard), regulatory affairs management, clinical study follow-up, communication strategy, and training for medical representatives. This generates revenue through contracted development fees and long-term supply agreements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Ekuberg Pharma develops, produces, and markets cosmetic products and medical devices (Class I, IIA, IIB, III) formulated with natural active ingredients and plant extracts across eight therapeutic areas: gynaecology, dermatology, otolaryngology, paediatrics, trichology, wound care, proctology, and andrology. The company sells branded product lines (Dermoxen, DermoACM, BioAke, Freenex, Liceout, Medoto, Lecoxen, Hemopran, Semyn) through 70+ international distribution partners and operates a private label division providing end-to-end custom formulation, regulatory affairs, clinical study management, and sales-force training for international pharmaceutical companies and large pharmacy distribution groups.

Product overview

Ekuberg Pharma is an Italian pharmaceutical company operating for over 25 years in research, development, production, and marketing of cosmetic products and medical devices. The company follows a 'family concept' business model and focuses on prevention and personal care. The product portfolio consists of multiple therapeutic sub-brands: Dermoxen® for gynaecology and women's intimate health; DermoACM® for dermatology and rheumatology (scleroderma treatment); BioAke and BioAke PLUS for skincare with CBD/hemp formulations; Freenex® for otolaryngology (nasal care); Liceout® for pediatric anti-lice treatment; Medoto™ for ear care; Lecoxen™ for wound care; Hemopran for proctology; and Semyn for andrology. The company also offers private label services and operates across 30+ countries. The products are developed through laboratory and clinical research with scientific publications supporting efficacy.

Differentiator

Problem solved

Functional benefit

Brands

• Dermoxen: Complete gynaecological health and well-being program for women, from childhood to menopause, including pregnancy and post-partum care, and as adjuvant in treatment of bacterial and fungal infections. Also covers intimate and personal hygiene for children.
• Freenex
• DermoACM
• Liceout
• BioAke
• Hemopran
• Medoto
• Semyn
• Lecoxen
• BioAke PLUS

Products and services

• Dermoxen Comprehensive program of gynaecological health products for women across all life stages, designed to prevent common gynaecological discomfort from childhood through menopause, support pregnancy and post-partum care, and serve as adjuvant support in pharmacological treatment of bacterial and fungal infections. Also covers paediatric intimate hygiene.
• DermoACM Dermatological treatment line clinically tested on patients with scleroderma, using plant-derived surfactants, absence of high-allergen preservatives/formaldehyde releasers, and latest-generation active ingredients including ceramides for skin barrier repair. Also developed for oncology and radiotherapy patient skin care.
• BioAke Cosmeceutical IN&OUT (topical plus systemic) treatment for oily, combination, and acne-prone skin, formulated with Cannabidiol (CBD) and hemp seed oil with a balanced 1:3 Omega 3 to Omega 6 ratio; clinically tested for skin barrier improvement and itch relief in one week.
• BioAke PLUS Oral food supplement based on Hemp Seed Oil with a balanced 1:3 Omega 3 to Omega 6 ratio, functional for skin health and to address menstrual cycle disorders, complementing the topical BioAke protocol as an IN&OUT treatment system.
• Freenex Medical device line of hypertonic and isotonic sea water solutions for decongestion and hygiene of nasal cavities, used as adjuvant therapy in treatment of chronic and allergic rhinitis, sinusitis, snoring, and post-operative nasal care.
• Liceout Anti-lice treatment line designed for paediatric use to address pediculosis (head lice) infestations in children.
• Medoto Spray for daily cleansing of the ear canal and prevention of cerumen (ear wax) plugs, classified as a medical device for routine otic hygiene.
• Lecoxen Wound care treatment for re-epithelialisation of acute and chronic skin lesions, including diabetic foot ulcers, pressure ulcers, surgical wounds, and first aid situations; clinically validated for wound healing and scar management.
• Hemopran Proctological treatment for prevention and management of haemorrhoidal disorders at all stages, formulated with functional natural actives and free from cortisone and anaesthetic, making it suitable for pregnant women and children.
• Semyn Food supplements developed in collaboration with specialists in medically assisted reproduction, urology, andrology, and gynaecology, supporting pharmacological treatment for reduced fertility, low sperm quality, and premature ejaculation.
• Private Label Development and Manufacturing Services Full-service private label development for international pharmaceutical companies and large pharmacy distribution groups (gruppi di acquisto della grande distribuzione farmaceutica), covering needs analysis, formula development, safety and efficacy testing (GLP-ECVAM standard), regulatory affairs management, clinical study follow-up, communication strategy, and briefing/training for medical representatives.

Quantifiable outcome

• DermoACM demonstrated statistically significant improvement in skin hydration (P=0.0012), trans-epidermal water loss reduction, and quality of life (DLQI, P<0.0001) in scleroderma patients after one month of combined cleanser and cream treatment alongside Iloprost therapy.
• +3 more outcomes

Named customers2 records

Segments8 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• UNIHEMP Project ConsortiumcoreStrategic or Co-development Partner · 1 January 2021Ekuberg Pharma is a partner in the UNIHEMP project, a European bioeconomy initiative co-funded by the Italian Ministry and the European Union (PON 2014-2020). The project aims to create a sustainable industrial model for the valorisation of waste from hemp cultivation, developing biochemicals for cosmetic and nutraceutical applications. The project aligns with Europa 2020 strategies for a sustainable bioeconomy.
• Italian and International Universities and Scientific ConsultantscoreStrategic or Co-development PartnerEkuberg Pharma's R&D workflow is certified by a team of scientific consultants and Italian and international universities. Collaborations include Università del Salento (Department of Hygiene, Science and Technology), U.O. Reumatologia 'A. Galateo' San Cesario di Lecce, and clinical dermatology specialists for product development and clinical study management.
• International Pharmaceutical Companies (Private Label Clients)coreChannel Partner/ Reseller/ DistributorEkuberg Pharma develops private label projects for international pharmaceutical companies and groups of pharmacy distributors, providing custom formulation, regulatory affairs, clinical study management, communication strategy, and training services for medical representatives.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Recordati: Italian specialty pharmaceutical company with a broad portfolio including dermatology, gynaecology, and rare disease products. Comparable to Ekuberg as a fellow Italian mid-cap pharma with multi-therapeutic-area coverage and a strong presence in Southern European and emerging markets.
• Zambon: Italian privately held pharmaceutical company with a portfolio spanning respiratory, women's health, and CNS. Comparable as an Italian mid-sized private pharma with international distribution and a focus on specialty therapeutic areas similar to Ekuberg's portfolio.
• Pierre Fabre: French privately held dermo-cosmetics and pharmaceutical company with strong dermatology, ENT, and oral care franchises. Comparable to Ekuberg's DermoACM dermatology line and Freenex/Medoto ENT devices from a product-category overlap perspective.
• Perrigo Company: Global consumer self-care company with strong private label and OTC store-brand businesses across skin care, women's health, and OTC remedies. Comparable to Ekuberg's private label B2B model and women's health/dermatology OTC positioning.

Direct peers

• Italfarmaco: Italian privately held pharmaceutical company focused on women's health, dermatology, and specialty care. Most directly comparable to Ekuberg given its Italian mid-size private profile, women's health and dermatology focus, and international distribution through partnerships.
• Doc Generici: Italian pharmaceutical company specialising in generics and private label manufacturing for pharmacy chains. Comparable to Ekuberg's private label B2B model serving large pharmacy distribution groups (gruppi di acquisto) across Italy and Europe.
• Molteni & C. dei F.lli Alitti: Italian specialty pharmaceutical company focused on pain management, addiction, and rare diseases with international partnerships. Comparable as an Italian mid-sized private pharma that distributes internationally via partner networks across multiple therapeutic niches.
• Abiogen Pharma: Italian privately held pharmaceutical company with a portfolio across bone metabolism, respiratory, and dermatology. Comparable to Ekuberg as an Italian private specialty pharma operating across multiple therapeutic areas with international distribution.
• Aboca: Italian natural-ingredient pharmaceutical and dermo-cosmetic company selling medical devices, supplements, and cosmetics across multiple therapeutic areas. Closely comparable to Ekuberg in its use of natural/botanical actives, multi-area portfolio, and Italian mid-size private profile.
• Laboratoires Expanscience: French privately held dermo-cosmetic and pharmaceutical company with strong women's health, dermatology, and wound care lines. Comparable to Ekuberg's gynaecology (Dermoxen), dermatology (DermoACM), and wound care (Lecoxen) franchises from a product-mix and European mid-market perspective.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Customer concentration

• LinkedInlinkedin.com/company/ekuberg-pharma-s-r-l

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ekuberg Pharma